Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-16

Clinical Trial Update: Prazosin for Smoking Cessation [Phase 2]

View source ↗

Summary

The Phase 2 trial of prazosin for smoking cessation in nicotine dependence was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prazosin (prazosin)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Nicotine Dependence | Phase 2 | Status: TERMINATED